Effects of non‐viable Lactobacillus reuteri combining with 14‐day standard triple therapy on Helicobacter pylori eradication: A randomized double‐blind placebo‐controlled trial

Double Blind Placebo ◽

Sequential Therapy Compared with Standard Triple Therapy for Helicobacter Pylori Eradication in Children: A Double-Blind, Randomized, Controlled Trial

The Journal of Pediatrics ◽

10.1016/j.jpeds.2011.01.023 ◽

2011 ◽

Vol 159 (1) ◽

pp. 45-49 ◽

Cited By ~ 18

Author(s):

Piotr Albrecht ◽

Maria Kotowska ◽

Hania Szajewska

Keyword(s):

Randomized Controlled Trial ◽

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Sequential Therapy ◽

Double Blind ◽

Randomized Controlled ◽

Sequential Therapy versus Standard Triple Therapy for Helicobacter Pylori Eradication in Iran: a double-blind, randomized, placebo-controlled trial

Electronic physician ◽

10.19082/7378 ◽

2019 ◽

Vol 11 (1) ◽

pp. 7378-7385

Author(s):

Seyed Hamid Moosavi ◽

Hamidreza Mahboobi ◽

Habib Dadvand

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Sequential Therapy ◽

Double Blind ◽

Efficacy of Lactoferrin with Standard Triple Therapy or Sequential Therapy for Helicobacter pylori Eradication: A Randomized Controlled Trial

10.5152/tjg.2021.20923 ◽

2021 ◽

Vol 32 (9) ◽

pp. 742-749

Author(s):

Fahmy H. Hablass ◽

◽

Sameh A. Lashen ◽

Eman A. Alsayed ◽

◽

...

Keyword(s):

Randomized Controlled Trial ◽

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Sequential Therapy ◽

Randomized Controlled ◽

Randomized, Double-blind, Placebo-controlled Trial: Effect of Lactobacillus GG Supplementation on Helicobacter Pylori Eradication Rates and Side Effects During Treatment in Children

Journal of Pediatric Gastroenterology and Nutrition ◽

10.1097/mpg.0b013e318182e716 ◽

2009 ◽

Vol 48 (4) ◽

pp. 431-436 ◽

Cited By ~ 63

Author(s):

Hania Szajewska ◽

Piotr Albrecht ◽

Agnieszka Topczewska-Cabanek

Keyword(s):

Helicobacter Pylori ◽

Side Effects ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Trial Effect ◽

Lactobacillus Gg

Absence of symptomatic benefit of lansoprazole, clarithromycin and amoxicillin (LCA) triple therapy is cure of helicobacter pylori (Hp) positive functional dyspepsia (FD) patients. A randomized double-blind placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(03)80911-3 ◽

2003 ◽

Vol 124 (4) ◽

pp. A183

Author(s):

Sander J. Veldhuyzen van Zanten ◽

Richard Fedorak ◽

Jean Lambert ◽

Lawrence Cohen ◽

Anita Vanjaka

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Functional Dyspepsia ◽

Controlled Trial ◽

Double Blind ◽

Positive Functional ◽

Double Blind Placebo ◽

Symptomatic Benefit

Addition of bismuth to standard triple therapy for Helicobacter pylori eradication: a randomised controlled trial

Journal of the Pakistan Medical Association ◽

10.5455/jpma.55396 ◽

2020 ◽

pp. 1

Author(s):

Muhammad Sharif ◽

Khurram Baqai ◽

Zaigham Abbas ◽

Nasir Laique ◽

Shoukat Samejo

Keyword(s):

Helicobacter Pylori ◽

Randomised Controlled Trial ◽

Triple Therapy ◽

Controlled Trial ◽

Standard Triple Therapy ◽

Randomised Controlled

Helicobacter pylori Eradication and Gastric Preneoplastic Conditions: A Randomized, Double-Blind, Placebo-Controlled Trial

Cancer Epidemiology Biomarkers & Prevention ◽

10.1158/1055-9965.epi-03-0124 ◽

2004 ◽

Vol 13 (1) ◽

pp. 4-10 ◽

Cited By ~ 81

Author(s):

C. Ley

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2016.06.012 ◽

2016 ◽

Vol 26 (10) ◽

pp. 893-898 ◽

Cited By ~ 14

Author(s):

A.R. Bonfigli ◽

M. Boemi ◽

R. Festa ◽

P. Bonazzi ◽

G. Brandoni ◽

...

Keyword(s):

Helicobacter Pylori ◽

Glucose Homeostasis ◽

Controlled Trial ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Type 2 Diabetic

Faculty Opinions recommendation of Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737893388.793576436 ◽

2020 ◽

Author(s):

Richard McCallum

Keyword(s):

Randomized Controlled Trial ◽

Helicobacter Pylori ◽

Triple Therapy ◽

Controlled Trial ◽

Double Blind ◽

Randomized Controlled

Long-term follow-up of patients with non-ulcer dyspepsia after Helicobacter pylori eradication. A randomized double-blind placebo-controlled trial

Gastroenterology ◽

10.1016/s0016-5085(98)81239-0 ◽

1998 ◽

Vol 114 ◽

pp. A305 ◽

Cited By ~ 1

Author(s):

N.J. Talley ◽

J. Janssens ◽

K. Lauritsen ◽

I. Rácz ◽

E. Bolling-Stermevald ◽

...

Keyword(s):

Helicobacter Pylori ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Long Term Follow Up ◽

Non Ulcer Dyspepsia